Unbiased AI-powered news
1 stories related to this topic, newest first.
ndtv.comThe Trump administration proposed altering a policy that prevents drugmakers from avoiding Medicare price negotiation by adding active ingredients to existing drugs. The change is part of an annual rule governing selection of the next 20 drugs and biologics for negotiation.